Science | ABNewswire

Whiteflash Sets a New Standard for Buying Loose Diamonds Online with Verified In-Stock Inventory and Advanced Imaging

See every detail before you buy. Whiteflash 360° HD diamond videos bring brilliance, fire, and precision into focus so you can choose with total confidence. Whiteflash simplifies the process to buy loose diamonds online by offering a physical, in-stock inventory … Continue reading →

Ecosense Expands Library Lending Program to Alabama with 250 EcoBlu™ Radon Detectors

Partnership with the Alabama Department of Public Health brings free, real-time radon testing to 33 libraries statewide. San Jose, Calif. – April 14, 2026 – Ecosense, a company recognized for providing radon detection and monitoring solutions, recently announced that its … Continue reading →

Hepatocellular Carcinoma Clinical Trial Pipeline Expands as 90+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Hepatocellular Carcinoma Pipeline Insight 2026 report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in the Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Diabetic Macular Edema Clinical Trial Pipeline Shows Potential with Active Contributions from 45+ Key Companies | DelveInsight

DelveInsight’s “Diabetic Macular Edema Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insights 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical … Continue reading →

HER2-Negative Breast Cancer Clinical Trial Pipeline Accelerates as 70+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “HER2-Negative Breast Cancer Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2-Negative Breast Cancer pipeline landscape. It covers the HER2-Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

TeroAI Invited to Participate in CES on the Hill 2026

Santa Monica, CA – April 14, 2026 – TeroAI, a leader in the AI geospatial sector, is proud to announce its invitation to participate in CES on the Hill 2026, taking place on April 22, 2026, in Washington, D.C. This invitation … Continue reading →

Dayhoff Health Reports 330× Increase in Microbiome Processing Speed Through AMD GPU Acceleration

GPU and Genomics Breakthrough Dayhoff Health and AMD publish a joint white paper documenting up to 330× faster microbiome processing, 13–22× faster whole genome sequencing, and 18–28× faster single-cell sequencing using AMD Radeon™ AI PRO R9700 GPUs. Results support high-throughput … Continue reading →

Neurofibromatosis Type 2 Treatment Pipeline Shows Strong Momentum as 5+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Neurofibromatosis Type 2 Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Neurofibromatosis Type 2 pipeline landscape. It covers the Neurofibromatosis Type 2 Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

HPV+ Recurrent/Metastatic Head and Neck Cancer Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the HPV+ Recurrent/Metastatic Head and Neck Cancer pipeline landscape. It covers the HPV+ Recurrent/Metastatic Head and Neck Cancer … Continue reading →

Saturday - April 18, 2026

Category Archives: Science